Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015, 159(1):100-103 | DOI: 10.5507/bp.2014.042
Incidence of fecal Enterobacteriaceae producing broad-spectrum beta-lactamases in patients with hematological malignancies
- a Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
- b Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc
- c Department of Hemato-Oncology, University Hospital Olomouc
Aim: Given the steadily increasing numbers of resistant bacteria, the frequency and severity of infections are on the rise. In patients with hematological malignancies, the treatment itself increases the risk of complicating bacterial infections. One important mechanisms of resistance is production of broad-spectrum beta-lactamases, increasingly detected not only in bacterial pathogens but also in bacteria contained in the normal microflora of the human body. The objectives of this study were determination and analysis of the prevalence of multiresistant ESBL- and AmpC-positive Enterobacteriaceae in the gastrointestinal tract (GIT) of patients with hematological malignancies.
Methods: For 3 months, rectal swabs were taken from patients with hematological malignancies and analyzed using chromogenic screening plates to isolate ESBL- and AmpC-producing Enterobacteriaceae. Beta-lactamase production was determined by phenotype tests and confirmed by detecting genes encoding ESBL and AmpC types. At the same time, ESBL- and AmpC-positive Enterobacteriaceae were isolated from clinical samples collected from patients with bacterial infection.
Results: Over the study period, fifteen patients (21%) of all patients treated at the Department of Hemato-Oncology were shown to have ESBL- or AmpC-positive Enterobacteriaceae in their GIT. Most frequently identified were ESBL-positive strains of Klebsiella pneumoniae and AmpC-positive strains of Citrobacter freundii. The ESBL enzymes were mainly of the CTX-M type. Isolates producing AmpC were found to contain genes for enzymes mainly from the CIT and DHA groups.
Conclusion: The study identified patients diagnosed with urinary tract and bloodstream infections caused by ESBL-positive strain of Klebsiella pneumoniae and AmpC-positive strain of Enterobacter cloacae contained in the GIT microflora.
Keywords: Enterobacteriaceae, ESBL, AmpC, fecal carriage
Received: March 10, 2014; Accepted: July 9, 2014; Prepublished online: August 18, 2014; Published: March 9, 2015 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Viscoli C, EORTC International Antimicrobial Therapy Group. Management of infection in cancer patients. Studies of the EORTC International Antimicrobial Therapy Group (IATG). Eur J Cancer 2002;38(Supp.4):S82-7.
Go to original source...
Go to PubMed...
- Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, di Grazia C, Frassoni F, Bacigalupo A, Viscoli C. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 2009;15(1):47-53.
Go to original source...
Go to PubMed...
- Trecarichi EM, Tumbarello M, Caira M, Candoni A, Cattaneo C, Pastore D, Fanci R, Nosari A, Vianelli N, Busca A, Spadea A, Pagano L. Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies. Haematologica 2011;96(1):e1-e3.
Go to original source...
Go to PubMed...
- Cattaneo C, Quaresmini G, Casari S, Capucci MA, Micheletti M, Borlenghi E, Signorini L, Re A, Carosi G, Rossi G. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother 2008;61(3):721-8.
Go to original source...
Go to PubMed...
- Kolar M, Htoutou Sedlakova M, Hanulik V and working group. Multi-resistant Gram-negative bacteria in haemato-oncologic patients. Postgrad Med 2012;14(5):6-10.
- Livermore DM. Fourteen years in resistance. Int J Antimicrob Agents 2012;39(4):283-94.
Go to original source...
Go to PubMed...
- Bush K, Jacoby GA. Updated Functional Classification of β-Lactamases. Antimicrob Agents Chemother 2010;54(3):969-76.
Go to original source...
Go to PubMed...
- Toussaint E, Bahel-Ball E, Vekemans M, Georgala A, Al-Hakak L, Paesmans M, Aoun M. Causes of fever in cancer patients (prospective study over 477 episodes). Support Care Cancer 2006;14(7):763-9.
Go to original source...
Go to PubMed...
- Kang CI, Chung DR, Ko KS, Peck KR, Song JH, Korean Network for Study of Infectious Diseases. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol 2012;91(1):115-21.
Go to original source...
Go to PubMed...
- Satlin MJ, Calfee DP, Chen L, Fauntleroy KA, Wilson SJ, Jenkins SG, Feldman EJ, Roboz GJ, Shore TB, Helfgott DC, Soave R, Kreiswirth BN, Walsh TJ. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leuk Lymphoma 2013;54(4):799-806.
Go to original source...
Go to PubMed...
- Arnan M, Gudiol C, Calatayud L, Liñares J, Dominguez MÁ, Batlle M, Ribera JM, Carratalà J, Gudiol F. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 2011;30(3):335-60.
Go to original source...
- Schaumann R, Knoop N, Genzel GH, Losensky K, Rosenkranz C, Stîngu CS, Schellenberger W, Rodloff AC, Eschrich K. A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. Med Sci Monit 2012;18(4):MT71-7.
Go to original source...
Go to PubMed...
- Htoutou Sedlakova M, Hanulik V, Chroma M, Hricova K, Kolar M, Latal T, Schaumann R, Rodloff AC. Phenotypic detection of broad-spectrum beta-lactamases in microbiological practice. Med Sci Monit 2011;17(5):BR147-52.
Go to original source...
Go to PubMed...
- Chanawong A, M'Zali FH, Heritage J, Lulitanond A, Hawkey PM. Characterisation of extended-spectrum ß-lactamases of the SHV family using a combination of PCR-single strand conformational polymorphism (PCR-SSCP) and PCR-restriction fragment length polymorphism (PCR-RFLP). FEMS Microbiol Lett 2000;184(1):85-9.
Go to original source...
Go to PubMed...
- Arlet G, Brami G, Décrè D, Flippo A, Gaillot O, Lagrange PH, Philippon A. Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiol Lett 1995;134(2-3):203-8.
Go to original source...
Go to PubMed...
- Pagani L, Dell'Amico E, Migliavacca R, D'Andrea MM, Giacobone E, Amicosante G, Romero E, Rossolini GM. Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol 2003;41(9):4264-9.
Go to original source...
Go to PubMed...
- Minarini LA, Gales AC, Palazzo IC, Darini AL. Prevalence of community-occurring extended spectrum b18.Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002;40(6):2153-62.
Go to original source...
Go to PubMed...
- Husickova V, Cekanova L, Chroma M, Htoutou-Sedlakova M, Hricova K, Kolar M. Carriage of ESBL- and AmpC-positive Enterobacteriaceae in the gastrointestinal tract of community subjects and hospitalized patients in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012;156(4):348-53.
Go to original source...
Go to PubMed...
- Calatayud L, Arnan M, Liñares J, Dominguez MA, Gudiol C, Carratalà J, Batlle M, Ribera JM, Gudiol F. Prospective study of fecal colonization by extended-spectrum-β-lactamase-producing Escherichia coli in neutropenic patients with cancer. Antimicrob Agents Chemother 2008;52(11):4187-90.
Go to original source...
Go to PubMed...
- Liss BJ, Vehreschild JJ, Cornely OA, Hallek M, Fätkenheuer G, Wisplinghoff H, Seifert H, Vehreschild MJ. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection 2012;40(6):613-9.
Go to original source...
Go to PubMed...
- Canton R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006;9(5):466-75.
Go to original source...
Go to PubMed...
- Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59(2):165-74.
Go to original source...
Go to PubMed...
- Korona-Glowniak I, Grywalska E, Chudzik B, Bojarska-Junak A, Malm A, Rolinski J. Upper respiratory tract colonization by gram-negative rods in patients with chronic lymphocytic leukemia: Analysis of risk factors. Scientific World Journal 2012:617218. doi: 10.1100/2012/617218.
Go to original source...
Go to PubMed...
- Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, Domingo-Domenech E, Jiménez L, Carratalà J. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect 2013;19(5):474-79.
Go to original source...
Go to PubMed...
- Gudiol C, Bodro M, Simonetti A, Tubau F, Gonzalez-Barca E, Cisnal M, Domingo-Domenech E, Jimenez L, Carratala J. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect 2013;19(5):474-79.
Go to original source...
Go to PubMed...